✦ LIBER ✦

Management of Favorable-Risk Patients With Metastatic Renal Cell Carcinoma: When to Start and When to Stop Targeted Therapy

✍ Scribed by Thomas Powles; Peter Albers

Book ID: 118430464
Publisher: CIG Media Group, LP.
Year: 2012
Tongue: English
Weight: 273 KB
Volume: 10
Category: Article
ISSN: 1558-7673
DOI: 10.1016/j.clgc.2012.06.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Management of adverse events of targeted

Management of adverse events of targeted therapies in normal and special patients with metastatic renal cell carcinoma

✍ María José Méndez-Vidal,Esther Martínez Ortega… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 290 KB

The association of clinical outcome to f

The association of clinical outcome to first-line VEGF-targeted therapy with clinical outcome to second-line VEGF-targeted therapy in metastatic renal cell carcinoma patients

✍ Mhd Y. Al-Marrawi, Brian I. Rini, Lauren C. Harshman, Georg Bjarnason… 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 269 KB

Editorial Comment to Therapy management

Editorial Comment to Therapy management of cardiovascular adverse events in the context of targeted therapy for metastatic renal cell carcinoma

✍ Alain Ravaud 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

726 DIFFERENCE OF RESPONSE TO TARGETED T

726 DIFFERENCE OF RESPONSE TO TARGETED THERAPY BETWEEN THE PRIMARY TUMOR AND METASTATIC LESIONS IN PATIENTS WITH ADVANCED RENAL CELL CARCINOMA

✍ M. Nozawa; N. Matsumura; M. Yasuda; Y. Okuda; H. Uemura 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 196 KB

1140 Categories of response to first lin

1140 Categories of response to first line VEGF receptor targeted therapy and overall survival in patients with metastatic renal cell carcinoma

✍ Busch, J.F.; Seidel, C.; Goranova, I.; Erber, B.; Peters, R.; Friedersdorff, F.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 108 KB

1917 PROGNOSITIC SIGNIFICANCE OF C-REACT

1917 PROGNOSITIC SIGNIFICANCE OF C-REACTIVE PROTEIN IN INTERMEDIATE-RISK JAPANESE METASTATIC RENAL CELL CARCINOMA PATIENTS TREATED WITH MOLECULAR TARGETED THERAPY

✍ Teishima, Jun; Hayashi, Tetsutaro; Seno, Yasuyuki; Ikeda, Kenichiro; Oka, Kiyota 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 50 KB